Institutional Animal Care and Use Committee
Reg. No. 200604393R
Application for Approval of Animal Use Protocol (AUP)
1. Please refer to the NTU-IACUC Policies for Special Procedures before submitting this application.
2. In order to perform its obligations in accordance with the NTU-IACUC Policies for
Special Procedures, it needs a complete description of the proposed animal use and care. Incomplete application will be returned to the applicant resulting in delay in the granting of approval.
3. Hand-written documents will not be accepted for review.
4. Submission is to be made on the prescribed form electronically or by email, and accompanied by a signed hard copy to:
All enquiries should be directed to the Secretariat (Lee Shok Li: iacuc@ntu.edu.sg
)
5. Any changes to the approved Animal Use Protocol (AUP) (procedure, species, personnel, etc.) must be documented through submission of an Amendment Form and approved by the NTU-IACUC before implementation. a) Any SIGNIFICANT changes to an approved project in progress (e.g. the inclusion of new procedures involving potential pain, surgery or anaesthetization, or a change in
Principal Investigator or course director) require IACUC review (and approval) prior to initiation. b) Any NON-SIGNIFICANT changes to an approved project in progress (e.g. increase in number of animals used within 15%, changes in location of experiment or changes in personnel) require administrative review (and approval) prior to initiation.
6. Approval of AUP will be for a maximum of 3 years . Following this, a new application is required.
Version: IACUC_AUPFORM_V03.1
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
0 of 16
Institutional Animal Care and Use Committee
Official Use Only
Protocol No.:
Approval Date:
Expiry Date:
Reg. No. 200604393R
This completed Animal Use Protocol (AUP) Application needs to be submitted to and approved by the NTU-IACUC prior to commencement of the animal study.
Application No.:
Date Status Remarks Signature
1 st Draft received by manager
1 st Draft Pre-review by attending vet
1 st Draft hard copy returned to PI for modifications
1 st Draft hard copy with amendments returned to manager
2 nd Draft Pre-review by attending vet
2 nd Draft submission to IACUC for approval
Version: IACUC_AUPFORM_V03.1
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
0 of 16
Institutional Animal Care and Use Committee
Protocol No.:
Draft:
Changes on this page: Y / N
Reg. No. 200604393R
SECTION 1a: PRINCIPAL INVESTIGATOR/COURSE INSTRUCTOR
Principal Investigator here refers to the main person responsible for the care and use of animals in this protocol (i.e. not necessarily be the grant holder).
Full Name:
Academic Title:
Department:
Email:
Tel:
Fax:
Mobile:
Experience or trained working with animals ? Please tick.
YES*
NO #
*Please provide evidence, include certificate of training, publication involving animal studies.
# Provide tentative date for training (dd-mmm-yy).
SECTION 1b: DESIGNATED EMERGENCY CONTACT(S)
Full Name Mobile phone Email
SECTION 1c: CO-INVESTIGATOR(S)/RESEARCH ASSISTANTS
List the names of all other individuals (besides the PI) authorised to conduct procedures involving animals under this protocol.
*Please provide evidence, include certificate of training, publication involving animal studies.
#
Provide tentative date for training (dd-mmm-yy).
Full Name:
Academic Title:
Department:
Email:
Experience or trained working with animals ? Please tick.
Mobile:
YES*
NO #
Full Name:
Academic Title:
Tel:
Fax:
Tel:
Fax:
Department:
Email:
Experience or trained working with animals ? Please tick.
YES*
Mobile:
Version: IACUC_AUPFORM_V03.1
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
2 of 16
Institutional Animal Care and Use Committee
Reg. No. 200604393R
NO #
Full Name:
Academic Title:
Department:
Email:
Tel:
Fax:
Mobile:
Experience or trained working with animals ? Please tick.
YES*
NO #
SECTION 1d: OCCUPATIONAL HEALTH AND SAFETY
Tetanus and Hepatitis B vaccinations are compulsory for personnel working with rodents.
Have all personnel been vaccinated?
Yes
No. They will all be vaccinated by (dd/mm/yy):
SECTION 2: PROJECT TITLE
2a. Project Title (In lay terminology, please give a descriptive title of your research project or course taught):
2b. Please specify the type of AUP application ( ☒ all that apply):
Research
Pilot study
Breeding protocol
Teaching
Others Please specify:
2c. Proposed length of study using animals (dd-mmm-yy):
Each protocol is only valid for 3 years.
Start date: End date:
SECTION 3: FUNDING
Grant type:
Others:
Funding status: Awarded
Pending
* Please check the appropriate box.
Date awarded:
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
3 of 16
Institutional Animal Care and Use Committee
Reg. No. 200604393R
SECTION 4: Research Animal Requirements
Please provide a summary of the research animal requirements. All fields are compulsory.
Common Animal Name:
Species:
Age at acquisition:
Weight at acquisition (metric):
Total Quantity required
(includes breeding animals and animals to be bred) :
No. housed at any one time (please check if sufficient room is available in the facility with lab manager):
Source of Animals*: Local
Source Address:
Overseas
Location of housing*: NTU ARF L1 NTU ARF L2 NIE
Other descriptions:
* Please tick where applicable.
BREEDING PLAN (If any)
Determine the number of breeding pairs you need to supply sufficient mice for your experiments. The following links may help you: http://jaxmice.jax.org/support/husbandry/colonySizeWkSht.pdf
http://www.bu.edu/orc/files/2013/06/JaxColony_Management_brdng.pdf
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
4 of 16
Institutional Animal Care and Use Committee
Reg. No. 200604393R
SECTION 5: LAY DESCRIPTION
Provide a typed abstract of 250 words or fewer in simple language. Outline the objectives of the project, the experimental approach, and the significance of the expected results to human and/or animal health.
List of specific objectives of project:
Abstract of 250 words or less in simple language:
Flowchart of experimental procedures and timelines:
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
5 of 16
Institutional Animal Care and Use Committee
Reg. No. 200604393R
Significance of expected benefits to humans or animals:
SECTION 6 (a-d ): JUSTIFICATION OF ANIMAL USE AND THE THREE R’s
The IACUC requires “that animals should be used only if the researcher’s best efforts to find an alternative have failed ”. The three Rs (Replacement, Reduction and Refinement) are the cornerstone of ethical animal research, and NTU-IACUC requires investigators to implement the 3Rs when they are preparing to use animals for scientific or teaching purposes.
6a.
Are there alternative non-animal methods used by other investigators for the type of work proposed in this AUP (e.g. tissue cultures, in vitro monoclonal antibody, computer model, etc)? If yes, describe why these alternatives are not appropriate for this project.
6b.
Why must animals be used in these experiments ( ☒ all that apply)?
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
6 of 16
Institutional Animal Care and Use Committee
Reg. No. 200604393R
This is a study of animal behaviour
This phenomenon under study cannot be reproduced in vitro
This is a pre-clinical study of the in vivo effectiveness of a treatment or procedure
This is for teaching
Others (elaborate in the space below)
6c.
What characteristics of this/these species make them appropriate for the proposed study? These might include structural, behavioural, physiological, biochemical, or other features or considerations (such as availability of species-specific reagents, or the use of well-established model) which make the model compatible with the research objectives.
Cost is not a primary consideration .
6d.
Reduction, replacement and refinement: How have you considered the 3Rs?
(i) Reduction: How have you attempted to reduce the number of animals? Please describe.
(ii) Replacement: Have you considered statistical models in vitro work, instead of using animals etc.? Please describe.
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
7 of 16
Institutional Animal Care and Use Committee
Reg. No. 200604393R
(iii) Refinement: Have you considered pilot studies, how have you refined any surgical procedures or other manipulations? Please describe.
SECTION 7: CLASSIFICATION OF PAIN/DISTRESS
Please check one ☒ to classify the pain/distress to the animals to be used in this study.
7a. Classification
Classification 1:
NO pain, distress, or use of pain-relieving drugs. Routine procedures (e.g. injections, tattooing, blood sampling) should be reported with this classification.
Year 1
No. of animals
Year 2
Classification 2:
Year 3
Remarks
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
8 of 16
Institutional Animal Care and Use Committee
Reg. No. 200604393R
Accompanying pain or distress to the animals for which appropriate anaesthetics, analgesics, or tranquillising drugs will be used.
Year 1
No. of animals
Year 2 Year 3
Remarks
Classification 3*:
Accompanying pain or distress to the animals for which the use of appropriate anaesthetics, analgesic, or tranquillising drugs would have adversely affected the procedures, results, or interpretation of the research, experiments, surgery, or tests. A brief explanation of the procedures producing pain or distress in these animals and the reasons such drugs were not used can be given in part 7b .
Year 1
No. of animals
Year 2
Classification 4:
Year 3
Remarks
Animals being bred, conditioned, or held for scientific activities at each facility but not yet used for research purposes.
No. of animals
Year 2 Year 3
Remarks
Year 1
Total number of animals to use per year:
*7b. (only for Classification 3)
An explanation of the procedures producing pain or distress in these animals and the justification for not using appropriate anaesthetic, analgesic or tranquilising drugs must be provided below. Why must anaesthetics and/or analgesics not be used? Please justify.
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
9 of 16
Institutional Animal Care and Use Committee
Reg. No. 200604393R
7c.
Please justify the number of animals used as stated in section 7.a
. Provide a breakdown of how the total numbers are arrived at and demonstrate the distribution of animal numbers in different procedures. (E.g. 6 animals x 2 treatments x 2 replicates = 24 animals). If statistics are used (e.g.
2 test, Fisher’s Exact test, Student’s t-test, ANOVA), please describe the statistical analysis.
7d. Are pregnant animals used? If yes, please describe how you will take care of the offspring.
SECTION 8: SURGICAL/NON-SURGICAL INTERVENTION AND PAIN MANAGEMENT
8a.
Give details and description of the surgical procedures and pain management during, and/or after surgical intervention. Please specify the anaesthetic, analgesic, antibiotic and other drugs used in pain management.
8b. Methods of Induction and Maintenance of Anesthesia ( Not applicable)
No. Method Agent Used Dosage Route of Administration i. Tranquilization ii. Induction iii. Maintenance iv. Analgesia
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
10 of 16
Institutional Animal Care and Use Committee
Reg. No. 200604393R v. Antibiotics
8c. Survival Surgery Considerations i. Has adequate consideration been given to anaesthesia and analgesia (pre- and postoperation)? ii. Are all surgical instruments and consumables available? iii. How are surgical instruments sterilised and how is the sterility maintained? iv. Has adequate consideration been given to asepsis? Describe the method(s) for sterilising the surgical site and instruments. v. How is the site closed (including all layers)? Describe sutures used and suture method. vi. Where will the procedure be conducted? vii. If clips or non-absorbable sutures are used, when will they be removed? viii. Describe the relevant experience and training to qualify operator in performing this surgery.
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
11 of 16
Institutional Animal Care and Use Committee
Reg. No. 200604393R ix. How will the animals be monitored over the 72 hours post-surgery? How will records of this monitoring be carried out?
8d. Post-operative Plan: ( Not applicable )
Duration of post-operative care:
* Please delete where appropriate
*Hours / Days / Weeks
Please specify the agents that will be used for post-surgical care.
No. Agent Drug Name Dosage (mg/kg) i. Antibiotics ii. Analgesics iii. Other agents
8.e
Give details of the non-surgical procedure and pain management during, and/or after the procedure in live animal studies. Please specify the anaesthetic, analgesic, antibiotic and other drugs used in pain management.
8.c
List all procedures, manipulations, and/or measurements that will be performed on the animals. Include post-operative care, specify analgesics & anaesthetics with dosages and routes of administration, and special procedures used.
No.
*PROCEDURES
^Frequency
No. of animals involved
Pain/distress classification
(1, 2, 3 or 4)
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
12 of 16
Institutional Animal Care and Use Committee
No.
*PROCEDURES
^Frequency
No. of animals involved
Reg. No. 200604393R
Pain/distress classification
(1, 2, 3 or 4) i. ii. iii.
If you need more space for animals involved, please insert new rows.
*Including physical or chemical restraint, blood sampling, injection of compounds, e.g. antibiotics, chemicals, etc.
^If the same procedure is repeated on the same animal.
SECTION 9: EXPERIMENTAL AND/OR ANIMAL USE ENDPOINT
When experimental procedures produce animals that may become ill, it is necessary to define an endpoint to ensure that an experimental animal's discomfort, pain and/or distress is terminated, minimized or reduced.
9a.
Indicate any clinical conditions or abnormalities expected or that could arise as a result of the proposed study or teaching exercise (e.g. behavioural changes such as increased grooming, vocalization or postural changes, or physical abnormalities such as anorexia, dehydration, diarrhoea, etc.)
9b.
In terms of species-specific behavioural changes and physiological signs, list the criteria that will be used to trigger the decision to remove an animal from the teaching exercise or experiment, or to terminate the teaching exercise or experiment. If necessary, consult the
Attending Veterinarian for further advice.
9c.
Humane End points of the experiment:
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
13 of 16
Institutional Animal Care and Use Committee
Reg. No. 200604393R
Please identify end points of the experiment with justification.
Tumour size (specify growth in cm).
Weight loss (more than 20% of bodyweight over 1 week OR no more than 10% over 24 hr)
Inability to drink or eat.
Abnormal behavior such as vocalization, CNS signs, shivering, immobility, inactiveness
Clinical symptoms (e.g. lameness, ruffled fur/coat, dyspnea, vomiting, edema, discharges)
Signs of Toxicity
Wound infection/dehiscence(breakdown)
Vomiting of blood (Haematemesis)
Severe bleeding
Severe or chronic pain
Others._______________
Comments:
SECTION 10: ANIMAL DISPOSAL
10a.
Indicate how carcasses are to be discarded of after completion of the project/research.
Euthanasia [ ☒ select preferred technique(s)]:
Anaesthetic overdose. Agent:
Cervical dislocation*
Exsanguination (under anaesthesia)
Decapitation*
CO
2
*Please provide justification(s) for using physical methods of euthanasia, and state the location where it will be done:
10b.
Please specify the method of carcass disposal. (Include method of disposing contaminated organs/tissues):
SECTION 11: HAZARDOUS AGENTS & MATERIALS
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
14 of 16
Institutional Animal Care and Use Committee
Reg. No. 200604393R
Specify each agent/material to be used and hazardous dosage:
NOTE: If a Biosafety and/or Radiation Safety risk assessment is required then a separate application must be submitted to the relevant bodies.
Potential Hazard to Animals None
Biological
Chemical
Carcinogen
Drug
Ionizing Radiation
Other (i.e. allergen)
Potential Hazard to Humans None
Biological
Chemical
Carcinogen
Drug
Ionizing Radiation
Other (i.e. allergen)
11a. Have you conducted risk assessments (RA) for your project using the Workplace Risk
Assessment System (WRAS)? Please attach as appendices.
Yes
No. I will submit by (dd/mm/yy):
11b. Describe potential health risks to animals or humans. Specify any special animal care required because of the hazard(s) involved. Specify precautions to be taken by personnel.
Specify any special containment requirements (i.e. storage, waste/disposal requirements, etc).
SECTION 14: SIGNATURES
Your signature indicates that (check each box where applicable before signing):
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
15 of 16
Institutional Animal Care and Use Committee
1
Reg. No. 200604393R
Animals used in this research or teaching project will be cared for in accordance with the principles contained in Guide for the Care and
Use of Laboratory Animal (8th Edition) http://oacu.od.nih.gov/regs/guide/guide.pdf
2
You have considered alternative procedures that do not involve the use of living animals.
3
4
5
6
7
8
9
10
You will use the minimum number of animals consistent with objectives of described research/teaching program.
You have carefully selected the species that you propose to use.
You will use techniques and facilities that are in accordance with the
Guide for the Care and Use of Laboratory Animal (8th Edition) http://oacu.od.nih.gov/regs/guide/guide.pdf
You will notify the IACUC of any revisions to this AUP.
You will keep copies of all approved AUPs, revisions and amendments in an accessible file.
This project has been reviewed for scientific merit.
The consultant Attending Veterinarian has been contacted for consultation prior to AUP submission.
Animals housed in other Satellite Rooms
Animals from external sources need to be quarantined or housed according to the revised guidelines on animal quaratine.
11 Animals housed in Animal Facility
Approval from the IACUC is valid for a period of three (3) years . If required, AUP must be renewed after the expiry date even if no revisions are made. At the end of the animal experiment, a closure report of the animal use is to be for IACUC review.
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
16 of 16
Institutional Animal Care and Use Committee
AUP form completed by:
Email address
:
Principal Investigator’s signature
Supervisor’s signature and stamp
FOR IACUC OFFICE USE ONLY
Date signed
Date signed
Decision of NTU Institutional Animal Care and Use Committee (IACUC)
☐ Approved
☐ Approved Pending Minor Modification
☐ Withhold Approval Pending Justification and Clarification
Reg. No. 200604393R
This AUP form has been reviewed by the IACUC, and is approved based on the information provided
_________________________________________________________________________
Signature of IACUC Chair Date
Professor Law Sai-Kit, Alex
Date of AUP Approval:
Version: IACUC_AUPFORM_V03
Last updated: 29 August 2014
By: Lee Shok Li
NTU-IACUC Secretariat
17 of 16